Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | TUBB1 | Q9H4B7 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | CYP4Z1 | Q86W10 | 1/20 | 0.33 |
| ▸ | CYP4F11 | Q9HBI6 | 1/20 | 0.33 |
| ▸ | CYP4F12 | Q9HCS2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1611154 | 0.94 | TSHR (0.38) | TSHRTUBB1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL1610235 | 0.92 | TSHR (0.41) | TSHRALDH1A1 | |
| SCHEMBL1611361 | 0.92 | TSHR (0.41) | TSHRALDH1A1 | |
| SCHEMBL1612420 | 0.86 | TUBB1 (0.35) | TUBB1ALDH1A1 | |
| SCHEMBL1610157 | 0.81 | TUBB1 (0.37) | TUBB1CYP3A4CYP2D6CYP2C9CYP1A2 | |
| SCHEMBL1611086 | 0.79 | TUBB1 (0.39) | TUBB1PTGS1PTGS2 | |
| SCHEMBL1613191 | 0.78 | TSHR (0.37) | TSHRALDH1A1CYP19A1 | |
| SCHEMBL1609646 | 0.75 | CNR1 (0.37) | TSHRTUBB1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL1610627 | 0.75 | TSHR (0.34) | TSHRALDH1A1 | |
| SCHEMBL1611869 | 0.75 | TSHR (0.34) | TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110087034-A1 | Organic Semiconductor Material | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2011-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110087034-A1 | Organic Semiconductor Material | OR10J3, TST, OR51E2 | TSHR 2994/4885TUBB1 2607/4885CYP3A4 517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.